Adrenal pathophysiology: Lessons from the carney complex

Hormone Research

Volumn 64, Issue 3, 2005, Pages 132-139

  Groussin, Lionel ^a   Cazabat, Laure ^a   René Corail, Fernande ^a   Jullian, Eric ^a   Bertherat, Jérôme ^a  

^a INSTITUT COCHIN   (France)

Author keywords

Carney complex; Cushing's syndrome; Cyclic AMP; Primary pigmented nodular adrenocortical disease; PRKAR1A gene

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DEXAMETHASONE; PROTEIN SUBUNIT;

ADRENAL CORTEX INSUFFICIENCY; ADRENAL DISEASE; ADRENAL GLAND; CARNEY COMPLEX; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CUSHING SYNDROME; DIAGNOSTIC IMAGING; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; GENE CONTROL; GENE LOCATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; GERM LINE; HEART MYXOMA; HORMONE DETERMINATION; HUMAN; LENTIGINOSIS; MULTIGENE FAMILY; MUTATIONAL ANALYSIS; PATHOPHYSIOLOGY; PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SHORT SURVEY; SIGNAL TRANSDUCTION; SKIN PIGMENTATION;

ADRENAL CORTEX DISEASES; ADRENAL GLANDS; ADULT; CHILD, PRESCHOOL; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA; PITUITARY ACTH HYPERSECRETION; PROTEINS; SIGNAL TRANSDUCTION;

EID: 27144504725     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088586     Document Type: Short Survey

References (31)

1. Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL: The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 1985;64:270-283.
2. Shenoy BV, Carpenter PC, Carney JA: Bilateral primary pigmented nodular adrenocortical disease: rare cause of the Cushing syndrome. Am J Surg Pathol 1984;8:335-344.
3. Carney JA, Young WF: Primary pigmented nodular adrenocortical disease and its associated conditions. Endocrinologist 1992;2:6-21.
4. Meador CK, Bowdoin B, Owen WC, Farmer TA: Primary adrenocortical nodular dysplasia: a rare cause of Cushing's syndrome. J Clin Endocrinol Metab 1967;27:1255-1263.
5. Bricaire H, Luton JP, Ghozland M, Forest M: La polymicroadé nomatose de la cortico-surrénale dans le syndrome de Cushing. Ann Med Interne (Paris) 1970;121:755-777.
6. de Gennes JL, Garnier H, Calmette, Malinsky M, Bertrand C: Etude clinique, biologique et histologique d'un cas exemplaire de polymicroadé nomatose cortico-surrénale. Ann Endocrinol (Paris) 1970;31:1022-1038.
7. Ruder HJ, Loriaux DL, Lipsett MB: Severe osteopenia in young adults associated with Cushing's syndrome due to micronodular adrenal disease. J Clin Endocrinol Metab 1974;39:1138-1147.
8. Stratakis CA, Carney JA, Lin JP, Papanicolaou DA, Karl M, Kastner DL, Pras E, Chrousos GP: Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest 1996;97:699-705.
9. Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS, Stratakis CA: Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 2000;26:89-92.
10. Casey M, Vaughan CJ, He J, Hatcher CJ, Winter JM, Weremowicz S, Montgomery K, Kucherlapati R, Morton CC, Basson CT: Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex. J Clin Invest 2000;106:R31-R38.
11. Stratakis CA, Sarlis N, Kirschner LS, Carney JA, Doppman JL, Nieman LK, Chrousos GP, Papanicolaou DA: Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Ann Intern Med 1999;131:585-591.
12. Groussin L, Jullian E, Perlemoine K, Leheup B, Luton JP, Bertagna X, Bertherat J: Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease (PPNAD). J Clin Endocrinol Metab 2002;87:4324-4329.
13. Gunther DF, Bourdeau I, Matyakhina L, Cassarino D, Kleiner DE, Griffin K, Courkoutsakis N, Abu-Asab M, Tsokos M, Keil M, Carney JA, Stratakis CA: Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity? J Clin Endocrinol Metab 2004;89:3173-3182.
14. Caticha O, Odell WD, Wilson DE, Dowdell LA, Noth RH, Swislocki AL, Lamothe JJ, Barrow R: Estradiol stimulates cortisol production by adrenal cells in estrogen-dependent primary adrenocortical nodular dysplasia. J Clin Endocrinol Metab 1993;77:494-497.
15. Storr HL, Mitchell H, Swords FM, Main KM, Hindmarsh PC, Betts PR, Shaw NJ, Johnston DI, Clark AJ, Reznek RH, Grossman AB, Savage MO: Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing's syndrome due to primary nodular adrenocortical hyperplasia. Clin Endocrinol (Oxf) 2004;61:553-559.
16. Bourdeau I, Lacroix A, Schurch W, Caron P, Antakly T, Stratakis CA: Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor. J Clin Endocrinol Metab 2003;88:3931-3937.
17. Sarlis NJ, Chrousos GP, Doppman JL, Carney JA, Stratakis CA: Primary pigmented nodular adrenocortical disease: reevaluation of a patient with Carney complex 27 years after unilateral adrenalectomy. J Clin Endocrinol Metab 1997;82:1274-1278.
18. Kirschner LS, Sandrini F, Monbo J, Lin JP, Carney JA, Stratakis CA: Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex. Hum Mol Genet 2000;9:3037-3046.
19. Groussin L, Kirschner L, Vincent-Dejean C, Perlemoine K, Jullian E, Delemer B, Zacharieva S, Pignatelli D, Carney JA, Luton JP, Bertagna X, Stratakis CA, Bertherat J: Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology. Am J Hum Genet 2002;71:1432-1442.
20. Veugelers M, Wilkes D, Burton K, McDermott DA, Song Y, Goldstein MM, La Perle K, Vaughan CJ, O'Hagan A, Bennett KR, Meyer BJ, Legius E, Karttunen M, Norio R, Kaariainen H, Lavyne M, Neau JP, Richter G, Kirali K, Farnsworth A, Stapleton K, Morelli P, Takanashi Y, Bamforth JS, Eitelberger F, Noszian I, Manfroi W, Powers J, Mochizuki Y, Imai T, Ko GT, Driscoll DA, Goldmuntz E, Edelberg JM, Collins A, Eccles D, Irvine AD, McKnight GS, Basson CT: Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice. Proc Natl Acad Sci U S A 2004;101:14222-14227.
21. Bertherat J, Groussin L, Sandrini F, Matyakhina L, Bei T, Stergiopoulos S, Papageorgiou T, Bourdeau I, Kirschner LS, Vincent-Dejean C, Perlemoine K, Gicquel C, Bertagna X, Stratakis CA: Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity. Cancer Res 2003;63:5308-5319.
22. Matyakhina L, Pack S, Kirschner LS, Pak E, Mannan P, Jaikumar J, Taymans SE, Sandrini F, Carney JA, Stratakis CA: Chromosome 2 (2p16) abnormalities in Carney complex tumours. J Med Genet 2003;40:268-277.
23. Kjellman M, Roshani L, Teh BT, Kallioniemi OP, Hoog A, Gray S, Farnebo LO, Holst M, Backdahl M, Larsson C: Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16. J Clin Endocrinol Metab 1999;84:730-735.
24. Bossis I, Stratakis CA: Minireview: PRKAR1A: normal and abnormal functions. Endocrinology 2004;145:5452-5458.
25. Groussin L, René-Corail F, Jullian E, Bertagna X, Bertherat J: Frequent germline mutation of the PKA regulatory subunit 1 (PRKAR1A) in patients with Carney complex (CNC) and/or sporadic primary pigmented nodular adrenocortical disease (PPNAD). 12th Int Congr of Endocrinology, Lisbon, 2004, 0R46, p 110.
26. Groussin L, Jullian E, René-Corail F, Lefebvre H, Vantyghem MC, Chanson P, Conte-Devolx B, Bertagna X, Bertherat J: A low penetrance mutation in the regulatory subunit R1A of the PKA gene (PRKAR1A) responsible for primary pigmented nodular adrenocortical disease (PPNAD) in seven kindreds suggests a genotype/phenotype correlation in Carney complex (CNC). Endocr Soc 86th Annu Meet, New Orleans, 2004, 0R, pp 10-15.
27. Rosenberg D, Groussin L, Jullian E, Perlemoine K, Bertagna X, Bertherat J: Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues. Ann N Y Acad Sci 2002;968:65-74.
28. Amieux PS, Howe DG, Knickerbocker H, Lee DC, Su T, Laszlo GS, Idzerda RL, McKnight GS: Increased basal cAMP-dependent protein kinase activity inhibits the formation of mesoderm-derived structures in the developing mouse embryo. J Biol Chem 2002;277:27294-27304.
29. Griffin KJ, Kirschner LS, Matyakhina L, Stergiopoulos S, Robinson-White A, Lenherr S, Weinberg FD, Claflin E, Meoli E, Cho-Chung YS, Stratakis CA: Down-regulation of regulatory subunit type 1A of protein kinase A leads to endocrine and other tumors. Cancer Res 2004;64:8811-8815.
30. Griffin KJ, Kirschner LS, Matyakhina L, Stergiopoulos S, Robinson-White A, Lenherr S, Weinberg FD, Claflin E, Batista D, Bourdeau I, Voutetakis A, Sandrini F, Meoli EM, Bauer AJ, Cho-Chung YS, Bornstein SR, Carney JA, Stratakis CA: A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions. J Med Genet 2004;41:923-931.
31. Robinson-White A, Hundley TR, Shiferaw M, Bertherat J, Sandrini F, Stratakis CA: Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1/2. Hum Mol Genet 2003;12:1475-1484.